3_Exhibits E-G - Laserfiche WebLink

EXHIBIT E RECORDING REQUESTED BY AND WHEN RECORDED MAIL TO: City of Pleasanton City Clerk's Office 123 Main Street P.O.Box 520 Pleasanton,CA 94566 Exempt from Payment of Recording Fees Pursuant to Government Code§27383 SPACE ABOVE THIS LINE FOR RECORDER'S USE THIS DEVELOPMENT AGREEMENT ("Agreement") is made and entered into in the City of Pleasanton, California, on this day of , 2021, by and between the City of Pleasanton, a municipal corporation (the "City"), and 10x Genomics, Inc., a Delaware Corporation, (the"Developer")pursuant to the authority of California Government Code §§65864 et seq. RECITALS A. To strengthen the public planning process, encourage private participation in comprehensive planning and reduce the economic risk of development,the Legislature of the State of California enacted California Government Code §§65864 et seq. (the"Development Agreement Statute"), which authorizes City to enter into an agreement with any person having a legal or equitable interest in real property regarding the development of such property. B. Developer is the owner of certain real property located in the City of Pleasanton, County of Alameda, California consisting of approximately 14.750 acres at 1701 Springdale Avenue, Pleasanton, as shown in Exhibit A-1 (the "Property"). The Property was previously developed with a commercial retail shopping center comprised of approximately 163,500 square feet and related site improvements. C. Developer contemplates developing up to three buildings totaling approximately 381,062 square feet, a 6-story parking garage with 1,168 stalls, surface parking for 90 stalls, and related site improvements such as landscape modifications, stormwater treatment areas, and other related improvements (the"Project", as generally shown on the site plan on Exhibit A-2). D. The Project is proposed to be developed in two to three phases: Phase 1 would include construction of Building 1,a 2-and 3-story, 150,000 square foot operations facility located on the north portion of the Property and including resurfacing of 477 parking stalls in the existing parking lot (the "Phase 1"); Phase 2 would include construction of Building 2, an up to 4-story, 115,000 square foot research and development facility located on the eastern portion of the Property, as well as removal of 400 existing surface parking stalls and construction of a 6-story 354,000 square foot parking structure (the"Phase 2"); and Phase 3 would include construction of Building 3, an up to 4-story, 116,062 square foot research and development facility located on the southeastern portion of the Property, and a 36,000 square foot surface parking lot providing 90 surface parking stalls would be constructed south of the parking structure (the "Phase 3"). The 4412928_2 -1- Committee, Commission, and Task Force List Page 2 of 2 May 26, 2021